Global Filgrastim Market Growth 2025-2031

December 2025 | 81 pages | ID: G16E5F3C3D99EN
LP Information

Abstracts

The global Filgrastim market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Granulocyte - colony stimulating factor (G-CSF) is another name for filgrastim. In some cases, health care professionals may use the trade name Neupogen, Granix or Zarxio when referring to the generic drug name filgrastim.

United States market for Filgrastim is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Filgrastim is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Filgrastim is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Filgrastim players cover Amgen, SANDOZ INC, Teva, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Filgrastim Industry Forecast” looks at past sales and reviews total world Filgrastim sales in 2024, providing a comprehensive analysis by region and market sector of projected Filgrastim sales for 2025 through 2031. With Filgrastim sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Filgrastim industry.

This Insight Report provides a comprehensive analysis of the global Filgrastim landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Filgrastim portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Filgrastim market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Filgrastim and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Filgrastim.

This report presents a comprehensive overview, market shares, and growth opportunities of Filgrastim market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Lyophilized Powder
• Others

Segmentation by Application:

• Solid Tumor
• Lymphoma
• Kidney Cancer
• Lung Disease
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Amgen
• SANDOZ INC
• Teva

Key Questions Addressed in this Report

What is the 10-year outlook for the global Filgrastim market?

What factors are driving Filgrastim market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Filgrastim market opportunities vary by end market size?

How does Filgrastim break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Filgrastim Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Filgrastim by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Filgrastim by Country/Region, 2020, 2024 & 2031
2.2 Filgrastim Segment by Type
  2.2.1 Lyophilized Powder
  2.2.2 Others
2.3 Filgrastim Sales by Type
  2.3.1 Global Filgrastim Sales Market Share by Type (2020-2025)
  2.3.2 Global Filgrastim Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Filgrastim Sale Price by Type (2020-2025)
2.4 Filgrastim Segment by Application
  2.4.1 Solid Tumor
  2.4.2 Lymphoma
  2.4.3 Kidney Cancer
  2.4.4 Lung Disease
  2.4.5 Others
2.5 Filgrastim Sales by Application
  2.5.1 Global Filgrastim Sale Market Share by Application (2020-2025)
  2.5.2 Global Filgrastim Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Filgrastim Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Filgrastim Breakdown Data by Company
  3.1.1 Global Filgrastim Annual Sales by Company (2020-2025)
  3.1.2 Global Filgrastim Sales Market Share by Company (2020-2025)
3.2 Global Filgrastim Annual Revenue by Company (2020-2025)
  3.2.1 Global Filgrastim Revenue by Company (2020-2025)
  3.2.2 Global Filgrastim Revenue Market Share by Company (2020-2025)
3.3 Global Filgrastim Sale Price by Company
3.4 Key Manufacturers Filgrastim Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Filgrastim Product Location Distribution
  3.4.2 Players Filgrastim Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR FILGRASTIM BY GEOGRAPHIC REGION

4.1 World Historic Filgrastim Market Size by Geographic Region (2020-2025)
  4.1.1 Global Filgrastim Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Filgrastim Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Filgrastim Market Size by Country/Region (2020-2025)
  4.2.1 Global Filgrastim Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Filgrastim Annual Revenue by Country/Region (2020-2025)
4.3 Americas Filgrastim Sales Growth
4.4 APAC Filgrastim Sales Growth
4.5 Europe Filgrastim Sales Growth
4.6 Middle East & Africa Filgrastim Sales Growth

5 AMERICAS

5.1 Americas Filgrastim Sales by Country
  5.1.1 Americas Filgrastim Sales by Country (2020-2025)
  5.1.2 Americas Filgrastim Revenue by Country (2020-2025)
5.2 Americas Filgrastim Sales by Type (2020-2025)
5.3 Americas Filgrastim Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Filgrastim Sales by Region
  6.1.1 APAC Filgrastim Sales by Region (2020-2025)
  6.1.2 APAC Filgrastim Revenue by Region (2020-2025)
6.2 APAC Filgrastim Sales by Type (2020-2025)
6.3 APAC Filgrastim Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Filgrastim by Country
  7.1.1 Europe Filgrastim Sales by Country (2020-2025)
  7.1.2 Europe Filgrastim Revenue by Country (2020-2025)
7.2 Europe Filgrastim Sales by Type (2020-2025)
7.3 Europe Filgrastim Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Filgrastim by Country
  8.1.1 Middle East & Africa Filgrastim Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Filgrastim Revenue by Country (2020-2025)
8.2 Middle East & Africa Filgrastim Sales by Type (2020-2025)
8.3 Middle East & Africa Filgrastim Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Filgrastim
10.3 Manufacturing Process Analysis of Filgrastim
10.4 Industry Chain Structure of Filgrastim

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Filgrastim Distributors
11.3 Filgrastim Customer

12 WORLD FORECAST REVIEW FOR FILGRASTIM BY GEOGRAPHIC REGION

12.1 Global Filgrastim Market Size Forecast by Region
  12.1.1 Global Filgrastim Forecast by Region (2026-2031)
  12.1.2 Global Filgrastim Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Filgrastim Forecast by Type (2026-2031)
12.7 Global Filgrastim Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Amgen
  13.1.1 Amgen Company Information
  13.1.2 Amgen Filgrastim Product Portfolios and Specifications
  13.1.3 Amgen Filgrastim Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Amgen Main Business Overview
  13.1.5 Amgen Latest Developments
13.2 SANDOZ INC
  13.2.1 SANDOZ INC Company Information
  13.2.2 SANDOZ INC Filgrastim Product Portfolios and Specifications
  13.2.3 SANDOZ INC Filgrastim Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 SANDOZ INC Main Business Overview
  13.2.5 SANDOZ INC Latest Developments
13.3 Teva
  13.3.1 Teva Company Information
  13.3.2 Teva Filgrastim Product Portfolios and Specifications
  13.3.3 Teva Filgrastim Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Teva Main Business Overview
  13.3.5 Teva Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Filgrastim Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Filgrastim Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Lyophilized Powder
Table 4. Major Players of Others
Table 5. Global Filgrastim Sales by Type (2020-2025) & (MT)
Table 6. Global Filgrastim Sales Market Share by Type (2020-2025)
Table 7. Global Filgrastim Revenue by Type (2020-2025) & ($ million)
Table 8. Global Filgrastim Revenue Market Share by Type (2020-2025)
Table 9. Global Filgrastim Sale Price by Type (2020-2025) & (USD/MT)
Table 10. Global Filgrastim Sale by Application (2020-2025) & (MT)
Table 11. Global Filgrastim Sale Market Share by Application (2020-2025)
Table 12. Global Filgrastim Revenue by Application (2020-2025) & ($ million)
Table 13. Global Filgrastim Revenue Market Share by Application (2020-2025)
Table 14. Global Filgrastim Sale Price by Application (2020-2025) & (USD/MT)
Table 15. Global Filgrastim Sales by Company (2020-2025) & (MT)
Table 16. Global Filgrastim Sales Market Share by Company (2020-2025)
Table 17. Global Filgrastim Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Filgrastim Revenue Market Share by Company (2020-2025)
Table 19. Global Filgrastim Sale Price by Company (2020-2025) & (USD/MT)
Table 20. Key Manufacturers Filgrastim Producing Area Distribution and Sales Area
Table 21. Players Filgrastim Products Offered
Table 22. Filgrastim Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Filgrastim Sales by Geographic Region (2020-2025) & (MT)
Table 26. Global Filgrastim Sales Market Share Geographic Region (2020-2025)
Table 27. Global Filgrastim Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Filgrastim Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Filgrastim Sales by Country/Region (2020-2025) & (MT)
Table 30. Global Filgrastim Sales Market Share by Country/Region (2020-2025)
Table 31. Global Filgrastim Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Filgrastim Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Filgrastim Sales by Country (2020-2025) & (MT)
Table 34. Americas Filgrastim Sales Market Share by Country (2020-2025)
Table 35. Americas Filgrastim Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Filgrastim Sales by Type (2020-2025) & (MT)
Table 37. Americas Filgrastim Sales by Application (2020-2025) & (MT)
Table 38. APAC Filgrastim Sales by Region (2020-2025) & (MT)
Table 39. APAC Filgrastim Sales Market Share by Region (2020-2025)
Table 40. APAC Filgrastim Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Filgrastim Sales by Type (2020-2025) & (MT)
Table 42. APAC Filgrastim Sales by Application (2020-2025) & (MT)
Table 43. Europe Filgrastim Sales by Country (2020-2025) & (MT)
Table 44. Europe Filgrastim Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Filgrastim Sales by Type (2020-2025) & (MT)
Table 46. Europe Filgrastim Sales by Application (2020-2025) & (MT)
Table 47. Middle East & Africa Filgrastim Sales by Country (2020-2025) & (MT)
Table 48. Middle East & Africa Filgrastim Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Filgrastim Sales by Type (2020-2025) & (MT)
Table 50. Middle East & Africa Filgrastim Sales by Application (2020-2025) & (MT)
Table 51. Key Market Drivers & Growth Opportunities of Filgrastim
Table 52. Key Market Challenges & Risks of Filgrastim
Table 53. Key Industry Trends of Filgrastim
Table 54. Filgrastim Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Filgrastim Distributors List
Table 57. Filgrastim Customer List
Table 58. Global Filgrastim Sales Forecast by Region (2026-2031) & (MT)
Table 59. Global Filgrastim Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Filgrastim Sales Forecast by Country (2026-2031) & (MT)
Table 61. Americas Filgrastim Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Filgrastim Sales Forecast by Region (2026-2031) & (MT)
Table 63. APAC Filgrastim Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Filgrastim Sales Forecast by Country (2026-2031) & (MT)
Table 65. Europe Filgrastim Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Filgrastim Sales Forecast by Country (2026-2031) & (MT)
Table 67. Middle East & Africa Filgrastim Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Filgrastim Sales Forecast by Type (2026-2031) & (MT)
Table 69. Global Filgrastim Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Filgrastim Sales Forecast by Application (2026-2031) & (MT)
Table 71. Global Filgrastim Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Amgen Basic Information, Filgrastim Manufacturing Base, Sales Area and Its Competitors
Table 73. Amgen Filgrastim Product Portfolios and Specifications
Table 74. Amgen Filgrastim Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Amgen Main Business
Table 76. Amgen Latest Developments
Table 77. SANDOZ INC Basic Information, Filgrastim Manufacturing Base, Sales Area and Its Competitors
Table 78. SANDOZ INC Filgrastim Product Portfolios and Specifications
Table 79. SANDOZ INC Filgrastim Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. SANDOZ INC Main Business
Table 81. SANDOZ INC Latest Developments
Table 82. Teva Basic Information, Filgrastim Manufacturing Base, Sales Area and Its Competitors
Table 83. Teva Filgrastim Product Portfolios and Specifications
Table 84. Teva Filgrastim Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Teva Main Business
Table 86. Teva Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Filgrastim
Figure 2. Filgrastim Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Filgrastim Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Filgrastim Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Filgrastim Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Filgrastim Sales Market Share by Country/Region (2024)
Figure 10. Filgrastim Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Lyophilized Powder
Figure 12. Product Picture of Others
Figure 13. Global Filgrastim Sales Market Share by Type in 2025
Figure 14. Global Filgrastim Revenue Market Share by Type (2020-2025)
Figure 15. Filgrastim Consumed in Solid Tumor
Figure 16. Global Filgrastim Market: Solid Tumor (2020-2025) & (MT)
Figure 17. Filgrastim Consumed in Lymphoma
Figure 18. Global Filgrastim Market: Lymphoma (2020-2025) & (MT)
Figure 19. Filgrastim Consumed in Kidney Cancer
Figure 20. Global Filgrastim Market: Kidney Cancer (2020-2025) & (MT)
Figure 21. Filgrastim Consumed in Lung Disease
Figure 22. Global Filgrastim Market: Lung Disease (2020-2025) & (MT)
Figure 23. Filgrastim Consumed in Others
Figure 24. Global Filgrastim Market: Others (2020-2025) & (MT)
Figure 25. Global Filgrastim Sale Market Share by Application (2024)
Figure 26. Global Filgrastim Revenue Market Share by Application in 2025
Figure 27. Filgrastim Sales by Company in 2025 (MT)
Figure 28. Global Filgrastim Sales Market Share by Company in 2025
Figure 29. Filgrastim Revenue by Company in 2025 ($ millions)
Figure 30. Global Filgrastim Revenue Market Share by Company in 2025
Figure 31. Global Filgrastim Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Filgrastim Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Filgrastim Sales 2020-2025 (MT)
Figure 34. Americas Filgrastim Revenue 2020-2025 ($ millions)
Figure 35. APAC Filgrastim Sales 2020-2025 (MT)
Figure 36. APAC Filgrastim Revenue 2020-2025 ($ millions)
Figure 37. Europe Filgrastim Sales 2020-2025 (MT)
Figure 38. Europe Filgrastim Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Filgrastim Sales 2020-2025 (MT)
Figure 40. Middle East & Africa Filgrastim Revenue 2020-2025 ($ millions)
Figure 41. Americas Filgrastim Sales Market Share by Country in 2025
Figure 42. Americas Filgrastim Revenue Market Share by Country (2020-2025)
Figure 43. Americas Filgrastim Sales Market Share by Type (2020-2025)
Figure 44. Americas Filgrastim Sales Market Share by Application (2020-2025)
Figure 45. United States Filgrastim Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Filgrastim Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Filgrastim Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Filgrastim Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Filgrastim Sales Market Share by Region in 2025
Figure 50. APAC Filgrastim Revenue Market Share by Region (2020-2025)
Figure 51. APAC Filgrastim Sales Market Share by Type (2020-2025)
Figure 52. APAC Filgrastim Sales Market Share by Application (2020-2025)
Figure 53. China Filgrastim Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Filgrastim Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Filgrastim Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Filgrastim Revenue Growth 2020-2025 ($ millions)
Figure 57. India Filgrastim Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Filgrastim Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Filgrastim Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Filgrastim Sales Market Share by Country in 2025
Figure 61. Europe Filgrastim Revenue Market Share by Country (2020-2025)
Figure 62. Europe Filgrastim Sales Market Share by Type (2020-2025)
Figure 63. Europe Filgrastim Sales Market Share by Application (2020-2025)
Figure 64. Germany Filgrastim Revenue Growth 2020-2025 ($ millions)
Figure 65. France Filgrastim Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Filgrastim Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Filgrastim Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Filgrastim Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Filgrastim Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Filgrastim Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Filgrastim Sales Market Share by Application (2020-2025)
Figure 72. Egypt Filgrastim Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Filgrastim Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Filgrastim Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Filgrastim Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Filgrastim Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Filgrastim in 2025
Figure 78. Manufacturing Process Analysis of Filgrastim
Figure 79. Industry Chain Structure of Filgrastim
Figure 80. Channels of Distribution
Figure 81. Global Filgrastim Sales Market Forecast by Region (2026-2031)
Figure 82. Global Filgrastim Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Filgrastim Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Filgrastim Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Filgrastim Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Filgrastim Revenue Market Share Forecast by Application (2026-2031)